|
DA3
MCID: PSD020
|
Pseudohypoaldosteronism Type Ii malady |
|
Sources: 17Genetics Home Reference, 30NIH Rare Diseases, 33OMIM, 15GeneReviews, 22MalaCards See all sources Export this MalaCard |
NIH Rare Diseases: Gordon Syndrome is a rare, inherited type of distal arthrogryposis typically characterized by a combination of camptodactyly (a permanent fixation of several fingers in a flexed position), clubfoot (abnormal bending inward of the foot), and less frequently, cleft palate. Intelligence is usually normal. In some cases, additional abnormalities such as scoliosis or undescended testicles in males may be present. The range and severity of symptoms may vary from case to case. Gordon syndrome is thought to be inherited in an autosomal dominant or X-linked dominant manner. The exact cause remains unknown.30
MalaCards: Pseudohypoaldosteronism Type Ii, also known as pseudohypoaldosteronism type 2, is related to liddle syndrome and pseudohypoaldosteronism. An important gene associated with Pseudohypoaldosteronism Type Ii is PHA2A (Pseudohypoaldosteronism type II (gene A)), and among its related pathways are PI3K / Akt Signaling and Aldosterone-regulated sodium reabsorption. The compounds bendroflumethiazide and hydrochlorothiazide have been mentioned in the context of this disorder. Affiliated tissues include kidney, and related mouse phenotypes are cardiovascular system and renal/urinary system. Genetics Home Reference: Pseudohypoaldosteronism type 2 (PHA2) is a condition characterized by problems regulating the amount of sodium and potassium in the body. Sodium and potassium are important in the control of blood pressure, and their regulation occurs primarily in the kidneys.17 OMIM: 145260 GeneReviews summary for pha2 |
|
Sources: 43UMLS, 7diseasecard, 15GeneReviews, 33OMIM, 16GeneTests, 30NIH Rare Diseases, 17Genetics Home Reference, 32Novoseek See all sources |
|
|
Sources: 33OMIM See all sources |
Clinical features from OMIM: 145260
|
|
Sources: 4CenterWatch, 29NIH Clinical Center, 5ClinicalTrials, 43UMLS, 28NDF-RT See all sources |
Approved drugs:Search CenterWatch for pseudohypoaldosteronism type ii Drug clinical trials:Search ClinicalTrials for pseudohypoaldosteronism type ii Search NIH Clinical Center for pseudohypoaldosteronism type ii Search CenterWatch for pseudohypoaldosteronism type ii |
|
|
|
Sources: 22MalaCards See all sources |
MalaCards organs/tissues related to pseudohypoaldosteronism type ii:22Kidney
|
|
Sources: 25MGI See all sources |
MGI Mouse Phenotypes related to pseudohypoaldosteronism type ii:25
|
|
Sources: 35PubMed See all sources |
Articles related to pseudohypoaldosteronism type ii:
|
|
Sources: 1BioGPS See all sources |
![]() |
|
Sources: 3Cell Signaling Technology, 20KEGG See all sources |
Pathways related to pseudohypoaldosteronism type ii according to GeneDecks:
|
|
Sources: 32Novoseek , 9DrugBank, 34PharmGKB, 18HMDB, 42Tocris Bioscience See all sources |
Compounds related to pseudohypoaldosteronism type ii according to GeneDecks:(show all 14)
|
|
Sources: 12Gene Ontology See all sources |
Biological processes related to pseudohypoaldosteronism type ii according to GeneDecks:(show all 8)
Molecular functions related to pseudohypoaldosteronism type ii according to GeneDecks:
|
